UPDATE 2-Pharma execs weigh in on possible changes under Trump

NEW YORK, Dec 1 (Reuters) - Top executives from large U.S.

drugmakers on Thursday discussed for the first time possible

changes for the industry under President-elect Donald Trump,

and issues that have damaged the reputation of their industry.

Read more